LexDanaLexDanabeta
Inventor

CHAOMIN LI

Inventor
US

Overview

3→
Patents
2021–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry11%
PatentTitleYear
11,820,760Crystalline polymorphs of Bruton's tyrosine kinase inhibitors202311,230,547Purine inhibitors of human phosphatidylinositol 3-kinase delta202211,179,389Purine inhibitors of human phosphatidylinositol 3-kinase delta2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2022Patents assigned to MERCK SHARP & DOHME (2)· patent assignee history
2021–2023Based in US· patent location history
2023Patents assigned to BIOGEN MA INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME22021–2022
BIOGEN MA INC12023
Locations
LocationPatentsSpan
US32021–2023